Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The fibroblast growth factor-23 and Vitamin D emerge as nontraditional risk factors and may affect cardiovascular risk.

Journal of internal medicine - 1 Mar 2015

Masson S, Agabiti N, Vago T, Miceli M, Mayer F, Letizia T, Wienhues-Thelen U, Mureddu G F, Davoli M, Boccanelli A, Latini R

Abstract excerpt

OBJECTIVES: Fibroblast growth factor-23 (FGF-23) and vitamin D are hormones involved in phosphate homoeostasis. They also directly influence cardiomyocyte hypertrophy. We examined whether the relationships between levels of vitamin D or FGF-23, cardiac phenotype and outcome were independent of es...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Cross-Sectional Studies
Share to Fibroblast Growth Factor-23

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fibroblast Growth Factors

Share to Hypertrophy, Left Ventricular

Share to Prognosis

Share to Vitamin D

Share to Vitamin D Deficiency

Source

Identifiers

PMID: 24620922
DOI: 10.1111/joim.12232

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24620922-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The fibroblast growth factor-23 and Vitamin D emerge as nontraditional risk factors and may affect cardiovascular risk.PMID 24620922Read ↗

Fibroblast Growth Factor-23 and Frailty in Elderly Community-Dwelling Individuals: The Cardiovascular Health Study.Semantic proximity Read ↗

Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases: a Mendelian Randomisation studySemantic proximity Read ↗

Vitamin D receptor genetics on extracellular matrix biomarkers and hemodynamics in systolic heart failure.Semantic proximity Read ↗

Associations between vitamin D status, VDR gene polymorphisms and echocardiographic markers in Polish patients with cardiovascular disease.Semantic proximity Read ↗

Association of Genetically Predicted Fibroblast Growth Factor-23 with Heart FailureSemantic proximity Read ↗

Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases: A Mendelian Randomization Study.Semantic proximity Read ↗

Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes.Semantic proximity Read ↗

Polymorphisms related to the serum 25-hydroxyvitamin D level and risk of myocardial infarction, diabetes, cancer and mortality. The Tromsø Study.Semantic proximity Read ↗

Low Transferrin Saturation and Elevated C-Terminal FGF23 Define a High-Risk Phenotype for the Occurrence of Major Adverse Cardiovascular Events in Patients with Coronary Artery Disease.Semantic proximity Read ↗

Insulin-like growth factor-I gene polymorphism and risk of heart failure (the Rotterdam Study).Semantic proximity Read ↗

Genetic Variants in the Vitamin D Pathway, 25(OH)D Levels, and Mortality in a Large Population-Based Cohort Study.Semantic proximity Read ↗

1,25-Vitamin D3 promotes cardiac differentiation through modulation of the WNT signaling pathwaySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.